Bvf INC Increased Its Immune Design Corp (IMDZ) Stake by $7.91 Million as Shares Rose

June 27, 2018 - By Gregory Tomko

Big Money Sentiment decreased to 1.57 in Q1 2018. It has change of 0.35, from 2017Q4’s 1.92. The ratio fall due to IMDZ positioning: 11 sold and 12 reduced. 10 funds acquired holdings and 26 increased holdings. Investors holded 23.09 million in 2017Q4 but now own 21.61 million shares or 6.41% less. Alyeska Invest Grp LP reported 452,516 shs. Manufacturers Life Ins The has invested 0% of its capital in Immune Design Corp. (NASDAQ:IMDZ). New York State Common Retirement Fund has invested 0% in Immune Design Corp. (NASDAQ:IMDZ). Northern reported 322,441 shs. Balyasny Asset Management Limited holds 0% of its capital in Immune Design Corp. (NASDAQ:IMDZ) for 60,812 shs. Bancorporation Of America De invested in 14,085 shs. 4.44M are owned by Ecor1 Ltd Com. Alliancebernstein Ltd Partnership invested in 0% or 11,800 shs. Proquest Assocs Iv Ltd Llc has invested 4.69% of its capital in Immune Design Corp. (NASDAQ:IMDZ). Goldman Sachs Grp invested 0% in Immune Design Corp. (NASDAQ:IMDZ). California State Teachers Retirement Sys stated it has 50,518 shs or 0% of all its holdings. 1.18M are held by Fmr Llc. Ameriprise stated it has 0% of its capital in Immune Design Corp. (NASDAQ:IMDZ). Wells Fargo Communications Mn has invested 0% in Immune Design Corp. (NASDAQ:IMDZ). Tiaa Cref Inv Mngmt Ltd Liability Com stated it has 82,676 shs.

IMDZ had 5 sales and 0 buys since January 4, 2018. This’s net activity of $66,512. On Thursday, January 4 Brady Stephen R also sold $13,885 worth of Immune Design Corp. (NASDAQ:IMDZ). On Thursday, January 4 1,986 shs were sold by ter Meulen Jan Henrik, worth $8,282. Yurasov Sergey sold $2,816 worth of Immune Design Corp. (NASDAQ:IMDZ) on Thursday, January 4. On Thursday, January 4 Gombotz Wayne had sold 1,986 shs worth $8,282.

According to 2018Q1 SEC filling the Bvf Inc upped its stake in Immune Design Corp (IMDZ) by 179.37%. By buying 2.64M shares Bvf Inc made the stock popped up with 30.77%. The major pharmaceuticals company reported $13.55 million value for the 2018Q1. Now the hedge fund is holding 4.11M shares, compared to the 1.47 million from the previous quarter. $202.13 million is the market cap of Immune Design Corp. IMDZ is reaching $4.2 during the last trading session, after decreased 4.55%.Immune Design Corp. has volume of 42,118 shares. Since June 27, 2017 IMDZ has declined 47.53% and is downtrending. IMDZ underperformed by 60.10% the S&P500.

The Bvf Inc’s stake in Array Biopharma Inc (NASDAQ:ARRY) was reduced by 3.62 million shares to 5.06 million shares valued at $82.62M in 2018Q1, according to the filing. It operates about $999.89M and $986.48M US Long portfolio. Bvf Inc has cut its stake in Gtx Inc Del and also reduced its holding in Cti Biopharma Corp by 1.67M shares in the quarter, for a total of 6.93M shares.

More recent Immune Design Corp. (NASDAQ:IMDZ) news were posted by Nasdaq.com, Seekingalpha.com and Nasdaq.com. The first one has “Immune Design Presents Data on the Mechanism of Action of G100 via TLR4 Expressed in B Cell Malignancies at the …” as a title and was posted on June 25, 2018. The next is “Is Immune Design Worth A Second Look?” on June 12, 2018. And last was posted on June 01, 2018, called “Immune Design to Host June 4 Cancer Immunotherapy Event in Chicago and Present at Jefferies 2018 Global …”.

Immune Design Corp. (NASDAQ:IMDZ) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.